| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 32 |
| 1 | DEXAMETHASONE 1.5 MG | 32 |
| 2 | METHYLPREDNISOLONE | 29 |
| 3 | OMEPRAZOLE | 25 |
| 4 | OMEPRAZOLE MAGNESIUM | 25 |
| 5 | TACROLIMUS | 25 |
| 6 | RITUXIMAB | 24 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 8 | TACROLIMUS OINTMENT 0.1% | 22 |
| 9 | CYCLOSPORINE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBERDOMIDE | 1 | 0.0067 |
| 1 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 2 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 2 | 0.0032 |
| 3 | PAMABROM | 1 | 0.0027 |
| 4 | VINBLASTINE SULFATE | 5 | 0.0025 |
| 5 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 6 | ISATUXIMAB | 8 | 0.0014 |
| 7 | HUMAN INSULIN | 8 | 0.0011 |
| 8 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 9 | DANTROLENE SODIUM | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 80 |
| 1 | Proton Pump Inhibitor [EPC] | 37 |
| 2 | Benzodiazepine [EPC] | 28 |
| 3 | Alkylating Drug [EPC] | 26 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 26 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 6 | Loop Diuretic [EPC] | 22 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 21 |
| 8 | Proteasome Inhibitor [EPC] | 20 |
| 9 | Insulin Analog [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 1 | Glinide [EPC] | 4 | 0.0004 |
| 2 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 3 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Insulin [EPC] | 9 | 0.0002 |
| 8 | Anticholinergic [EPC] | 3 | 0.0002 |
| 9 | Proteasome Inhibitor [EPC] | 20 | 0.0002 |